Kalkine has a fully transformed New Avatar.

Switch to Old version
1800-272-662
Shopping Cart 0
countryflagAU
Login

Tilray Inc

Healthcare US TLRY

7.2USD
-0.15(2.04%)

Last update at 2026-03-10T20:28:00Z

Day Range

7.177.50
LowHigh

52 Week Range

1.503.40
LowHigh

Fundamentals

  • Previous Close 7.35
  • Market Cap1503.03M
  • Volume2521590
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA9.65M
  • Revenue TTM743.25M
  • Revenue Per Share TTM1.04
  • Gross Profit TTM 116.82M
  • Diluted EPS TTM-0.43

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Analyst Recommendations

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Income before tax -440.67400M -344.98600M -58.19245M -58.19245M -11.56319M
Minority interest -9.65600M -42.66900M 6.24M 25.81M 28.41M
Net income -434.13200M -336.01400M -61.01639M -61.01639M -12.19438M
Selling general administrative 162.80M 111.58M 88.30M 88.30M 70.83M
Selling and marketing expenses 65.86M 44.12M 29.92M 29.92M 20.67M
Gross profit 116.82M 123.18M 137.68M 137.68M 55.74M
Reconciled depreciation 130.15M 115.19M 18.65M 15.85M 3.56M
Ebit 153.29M -4.94700M -33.40927M 51.48M -2.59941M
Ebitda 268.49M 30.27M 2.11M 67.16M 14.36M
Depreciation and amortization 115.19M 35.22M 35.52M 15.68M 16.95M
Non operating income net other - - -36.34900M - -6.17900M
Operating income 153.29M -4.94700M -47.62341M 51.48M -2.59941M
Other operating expenses 856.92M 581.64M 389.07M 389.07M 222.44M
Interest expense 39.68M 30.90M 24.78M 24.78M 5.75M
Tax provision -7.18100M -6.54200M -5.60200M -8.45000M -4.45100M
Interest income 33.02M 11.74M 2.93M 0.76M 16.34M
Net interest income -13.58700M -27.94400M -39.21900M -33.92600M -9.11000M
Extraordinary items - - - - -
Non recurring - - 61.11M - -
Other items - - - - -
Income tax expense -6.54200M -8.97200M 2.82M 2.82M 0.63M
Total revenue 628.37M 513.09M 391.00M 391.00M 175.25M
Total operating expenses 345.37M 191.74M 135.75M 135.75M 102.94M
Cost of revenue 511.56M 389.90M 253.31M 253.31M 119.50M
Total other income expense net -593.96900M -340.03900M -10.56904M -109.67579M -8.96378M
Discontinued operations - - - - -
Net income from continuing ops -1443.00000M -434.13200M -271.07300M -321.16900M -67.72300M
Net income applicable to common shares - -434.13200M -271.07300M -321.16900M -67.72300M
Preferred stock and other adjustments - - - - -
Breakdown 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly yearly
Date 2023-12-31 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 4307.26M 5449.69M 6025.36M 1801.23M 1801.23M
Intangible assets 973.78M 1277.88M 1605.92M 261.73M 261.73M
Earning assets - - - - -
Other current assets 37.72M 46.79M 48.92M 42.92M 51.42M
Total liab 977.32M 1008.33M 1560.05M 475.89M 475.89M
Total stockholder equity 3315.69M 4398.81M 4459.07M 1306.74M 1306.74M
Deferred long term liab - - - 49.27M -
Other current liab 18.04M 119.09M 138.82M 138.82M 4.62M
Common stock 0.07M 0.05M 0.05M 1331.54M 1331.54M
Capital stock - 0.07M 0.05M 0.05M 1331.54M
Retained earnings -2415.50700M -962.85100M -486.05000M -44.13260M -44.13260M
Other liab - - 196.83M 53.89M 59.02M
Good will 2008.84M 2641.30M 2832.79M 445.50M 445.50M
Other assets - - 111.51M 4.36M 7.86M
Cash 206.63M 415.91M 488.47M 358.47M 358.47M
Cash and equivalents - - - - -
Total current liabilities 432.98M 280.34M 401.24M 122.84M 122.84M
Current deferred revenue 119.86M - 155.11M 0.65M 0.65M
Net debt 383.50M 207.90M 450.19M -58.14775M -58.14775M
Short term debt 224.26M 92.65M 49.60M 7.44M 7.44M
Short long term debt - 221.84M 85.95M 45.34M 1.50M
Short long term debt total 590.13M 623.81M 938.66M 300.32M 300.32M
Other stockholder equity 5777.74M 5382.37M 4792.41M 20.24M 20.24M
Property plant equipment - - 600.50M 199.56M 201.73M
Total current assets 773.03M 803.50M 883.61M 651.22M 651.22M
Long term investments - 12.37M 15.00M 23.67M 35.63M
Net tangible assets - - 479.62M 20.54M -106.80800M
Short term investments 241.90M 241.90M - 9.30M 11.45M
Net receivables 86.23M 95.28M 89.79M 59.27M 50.77M
Long term debt - 357.93M 519.83M 306.26M 430.21M
Inventory 200.55M 245.53M 256.43M 190.56M 190.56M
Accounts payable 70.82M 68.60M 57.71M 110.12M 110.12M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -46.61000M -20.76400M 152.67M -0.91488M -0.91488M
Additional paid in capital - - - - -
Common stock total equity - - - 1846.94M 0.01M
Preferred stock total equity - - - - -
Retained earnings total equity - - - -730.10300M -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other 0.22M 111.51M 8.29M 8.29M 0.00000M
Deferred long term asset charges - - - - -
Non current assets total 3534.23M 4646.19M 5141.75M 1150.01M 1150.01M
Capital lease obligations - 10.36M 18.03M 33.54M 31.88M
Long term debt total - - - 306.26M 444.36M
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Type yearly yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31 2018-12-31
Investments -285.11100M -21.53300M 0.30M -253.18100M -44.87600M
Change to liabilities - -44.65200M -30.75700M 20.00M 14.64M
Total cashflows from investing activities - -21.53300M -41.68000M -253.18100M -98.62000M
Net borrowings - -123.54600M 44.79M -1.00400M 417.65M
Total cash from financing activities 128.20M 124.31M 125.40M 125.40M 535.51M
Change to operating activities - 4.47M -15.67600M -23.10700M 6.83M
Net income -434.13200M -336.01400M -61.01639M -61.01639M -12.19438M
Change in cash -72.55700M 127.82M -38.62458M -38.62458M 362.94M
Begin period cash flow 488.47M 360.65M 397.09M 397.09M 44.15M
End period cash flow 415.91M 488.47M 358.47M 358.47M 407.09M
Total cash from operating activities -177.26200M -44.71700M -96.43061M -96.43061M -41.09756M
Issuance of capital stock 129.59M 262.51M 102.55M 71.90M 181.76M
Depreciation 154.59M 67.83M 35.52M 35.52M 16.95M
Other cashflows from investing activities - - 2.66M -2.68900M -3.54600M
Dividends paid -7484.00000M - - - -
Change to inventory -45.74900M -35.28600M -90.25428M -90.25428M -29.17443M
Change to account receivables -5.84200M -23.51200M -24.73415M -24.73415M 9.21M
Sale purchase of stock -1.18900M - 96.97M 111.52M 228.65M
Other cashflows from financing activities 7482.64M 87.38M 63.07M 63.07M 362.16M
Change to netincome - 236.72M 183.10M 157.98M 29.32M
Capital expenditures 34.06M 38.87M 95.47M 95.47M 152.23M
Change receivables - - 6.29M - -16.41100M
Cash flows other operating - - -15.81400M - -2.58800M
Exchange rate changes - - - - -
Cash and cash equivalents changes - - 93.82M - 486.13M
Change in working capital -91.77100M -50.93500M -82.95760M -82.95760M -15.88396M
Stock based compensation 35.99M 17.35M 16.22M 16.22M 19.28M
Other non cash items 185.59M 281.92M -2.23709M -2.23709M -46.22690M
Free cash flow -211.32600M -83.59100M -191.90019M -191.90019M -193.32594M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
TLRY
Tilray Inc		 -0.15 2.04% 7.20 - 1000.00 1.90 0.42 2.24 -12.9534
ZTS
Zoetis Inc		 -1.87 1.53% 120.49 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.56 2.23% 25.64 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -2.64 2.02% 128.01 21.73 14.95 3.16 2.15 3.56 12.82
TAK
Takeda Pharmaceutical Co Ltd ADR		 0.14 0.77% 18.21 32.67 11.53 0.01 0.87 0.02 0.07

Reports Covered

Stock Research & News

View All

Profile

Tilray Brands, Inc. engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Wellness Business. It also offers medical and adult-use cannabis products; purchases and resells pharmaceutical and wellness products; and produces, markets, sells, and distributes beverage alcohol products, and hemp-based food and other wellness products. In addition, the company offers its products under the Tilray, Aphria, Broken Coast, Symbios, B!NGO, The Batch, Dubon, Good Supply, Solei, Chowie Wowie, Canaca, RIFF, SweetWater, Breckenridge Distillery, Alpine Beer Company, and Green Flash brands. It sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.

Tilray Inc

265 Talbot Street West, Leamington, ON, Canada, N8H 5L4

Key Executives

Name Title Year Born
Mr. Irwin David Simon Pres, CEO & Chairman 1958
Mr. Carl A. Merton CA, CBV, CPA CFO & Principal Accounting Officer 1970
Mr. Mitchell S. Gendel Global Gen. Counsel & Corp. Sec. 1966
Mr. James R. Meiers Sr. VP of U.S. Operations 1958
Ms. Denise Menikheim Faltischek Chief Strategy Officer & Head of International 1973
Mr. Lloyd Brathwaite Chief Information Officer NA
Mr. Roger Savell Chief Admin. Officer NA
Mr. John B. Sadler VP of Investor Relations NA
Ms. Dara S. Redler Interim Chief Legal Officer & Corp. Sec. NA
Mr. Bernard Yeung Sr. VP of Sales & Marketing NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.